Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 514

1.

British Journal of Biomedical Science in 2018: what have we learned?

Blann A.

Br J Biomed Sci. 2019 Jan;76(1):1-10. doi: 10.1080/09674845.2018.1533702. Epub 2018 Nov 20.

PMID:
30295133
2.

British Journal of Biomedical Science in 2017: What have we learned?

Blann A.

Br J Biomed Sci. 2018 Jan;75(1):1-6. doi: 10.1080/09674845.2017.1374668. Epub 2017 Oct 18.

PMID:
29043909
3.

Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease.

Heitmar R, Lip GYH, Ryder RE, Blann AD.

Cardiovasc Diabetol. 2017 Apr 26;16(1):56. doi: 10.1186/s12933-017-0534-6.

4.

British Journal of Biomedical Science in 2016. What have we learned?

Blann A.

Br J Biomed Sci. 2017 Jan;74(1):1-7. doi: 10.1080/09674845.2016.1271567. Erratum in: Br J Biomed Sci. 2017 Oct;74(4):i.

PMID:
28206852
6.

The relationship of systemic markers of renal function and vascular function with retinal blood vessel responses.

Heitmar R, Varma C, De P, Lau YC, Blann AD.

Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2257-2265. Epub 2016 Jul 20.

7.

Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.

Lau YC, Xiong Q, Blann AD, Lip GY.

J Thromb Thrombolysis. 2017 Jan;43(1):18-23. doi: 10.1007/s11239-016-1427-3.

8.

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.

Lau YC, Proietti M, Guiducci E, Blann AD, Lip GYH.

J Am Coll Cardiol. 2016 Sep 27;68(13):1452-1464. doi: 10.1016/j.jacc.2016.06.057. Review. Erratum in: J Am Coll Cardiol. 2016 Dec 27;68(25):2921.

9.

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation.

Lau YC, Xiong Q, Shantsila E, Lip GY, Blann AD.

J Thromb Thrombolysis. 2016 Nov;42(4):535-44. doi: 10.1007/s11239-016-1399-3.

10.

Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function.

Lau YC, Hardy LJ, Philippou H, Blann AD, Lip GY.

Thromb Haemost. 2016 Aug 30;116(3):408-9. doi: 10.1160/TH16-05-0361. Epub 2016 Jun 30. No abstract available.

PMID:
27356648
11.

British Journal of Biomedical Science in 2015: what have we learned?

Blann A, Nation B.

Br J Biomed Sci. 2016;73(1):4-9. doi: 10.1080/09674845.2016.1154701.

PMID:
27182670
12.

The rolling evolution of biomedical science as an essential tool in modern clinical practice.

Blann A.

Br J Biomed Sci. 2016;73(1):1-3. doi: 10.1080/09674845.2016.1150665.

PMID:
27182669
13.

Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.

Lau YC, Xiong Q, Lip GY, Blann AD.

Ann Med. 2016;48(4):275-81. doi: 10.3109/07853890.2016.1166516. Epub 2016 Apr 4.

PMID:
27043881
14.

Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism.

Blann AD, Lip GY.

Heart. 2016 Jun 15;102(12):975-83. doi: 10.1136/heartjnl-2014-307019. Epub 2016 Mar 16. Review. No abstract available.

PMID:
26984888
16.

Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.

Blann AD, Pisters R, Lip GYH.

JACC Clin Electrophysiol. 2016 Feb;2(1):47-54. doi: 10.1016/j.jacep.2015.09.015. Epub 2015 Nov 10.

17.

Effects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery.

Sayed S, Idriss NK, Sayyedf HG, Ashry AA, Rafatt DM, Mohamed AO, Blann AD.

Br J Biomed Sci. 2015;72(3):93-101.

PMID:
26510263
18.

Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.

Blann AD, Banerjee A, Lane DA, Torp-Pedersen C, Lip GY.

Int J Cardiol. 2015 Dec 15;201:693-8. doi: 10.1016/j.ijcard.2015.08.074. Epub 2015 Aug 10.

PMID:
26379097
19.

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in.

Blann A.

Vasc Health Risk Manag. 2015 Aug 20;11:489-92. doi: 10.2147/VHRM.S89736. eCollection 2015. No abstract available.

20.

An update on vitamin D deficiency and at risk groups.

Blann A.

J Fam Health. 2015 May-Jun;25(3):16-9. Review.

PMID:
26118289
21.

Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.

Blann AD, Skjøth F, Rasmussen LH, Larsen TB, Lip GY.

Thromb Haemost. 2015 Aug;114(2):403-9. doi: 10.1160/TH15-05-0383. Epub 2015 Jun 11.

PMID:
26062437
22.
23.

The influence of age and metformin treatment status on reported gastrointestinal side effects with liraglutide treatment in type 2 diabetes.

Thong KY, Gupta PS, Blann AD, Ryder RE.

Diabetes Res Clin Pract. 2015 Jul;109(1):124-9. doi: 10.1016/j.diabres.2015.04.009. Epub 2015 Apr 20.

PMID:
25937541
24.

Development and validation of a new assay for assessing clot integrity.

Ranjit P, Lau Y, Lip GY, Blann AD.

Vascul Pharmacol. 2015 Aug;71:102-7. doi: 10.1016/j.vph.2015.02.013. Epub 2015 Apr 11.

PMID:
25872165
25.

A reliable marker of vascular function: Does it exist?

Blann AD.

Trends Cardiovasc Med. 2015 Oct;25(7):588-91. doi: 10.1016/j.tcm.2015.03.005. Epub 2015 Mar 11. No abstract available.

PMID:
25861960
26.

The Number of GT(n) Repeats in the Hemeoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory Markers.

Sayed S, Idriss NK, Blann A, Sayyed HG, Raafat DM, Fouad D, Tawfeek MS.

Pediatr Cardiol. 2015 Aug;36(6):1204-11. doi: 10.1007/s00246-015-1146-0. Epub 2015 Mar 31.

PMID:
25822459
27.

Renal, endothelial function, warfarin management, and the CHADS2, CHA2DS2VASc and HAS-BLED scores inpredicting MACE in AF.

Blann AD, Lip GY.

Thromb Haemost. 2015 May;113(5):1155-7. doi: 10.1160/TH14-11-0932. Epub 2015 Feb 26. No abstract available.

PMID:
25716989
28.

Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.

Ramcharan KS, Lip GY, Stonelake PS, Blann AD.

Int J Colorectal Dis. 2015 Mar;30(3):315-21. doi: 10.1007/s00384-014-2116-3. Epub 2015 Jan 20.

PMID:
25598043
29.

Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory.

Blann AD.

Br J Biomed Sci. 2014;71(4):158-67. Review.

PMID:
25562993
30.

Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.

Kornej J, Dinov B, Blann AD, Rolf S, Arya A, Schmidl J, Husser D, Hindricks G, Bollmann A, Lip GY.

PLoS One. 2014 Nov 12;9(11):e111760. doi: 10.1371/journal.pone.0111760. eCollection 2014.

31.

Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project.

Guo Y, Apostalakis S, Blann AD, Lip GY.

Cerebrovasc Dis. 2014;38(3):204-11. doi: 10.1159/000365841. Epub 2014 Oct 9.

PMID:
25301077
32.

Laboratory monitoring of the non-vitamin K oral anticoagulants.

Blann AD, Lip GY.

J Am Coll Cardiol. 2014 Sep 16;64(11):1140-2. doi: 10.1016/j.jacc.2014.07.010. No abstract available.

33.

Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer.

Ramcharan KS, Lip GY, Stonelake PS, Blann AD.

Br J Cancer. 2014 Oct 28;111(9):1742-9. doi: 10.1038/bjc.2014.491. Epub 2014 Sep 11.

34.

Circulating Endothelial Cells and Platelet Microparticles in Mitral Valve Disease With and Without Atrial Fibrillation.

Idriss NK, Blann AD, Sayed DM, Gaber MA, Hassen HA, Kishk YT.

Angiology. 2015 Aug;66(7):631-7. doi: 10.1177/0003319714546183. Epub 2014 Aug 12.

PMID:
25115553
35.

Functions and diseases of red and white blood cells.

Blann A.

Nurs Times. 2014 Feb 19-25;110(8):16-8.

PMID:
24683693
36.

Blood tests and age-related changes in older people.

Blann A.

Nurs Times. 2014 Feb 12-18;110(7):22-3.

PMID:
24672911
37.

What is the purpose of liver function tests?

Blann A.

Nurs Times. 2014 Feb 5-11;110(6):17-9. Review.

PMID:
24669469
38.

Why do we test for urea electrolytes?

Blann A.

Nurs Times. 2014 Jan 29-Feb 4;110(5):19-21.

PMID:
24600964
39.

No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.

Kuzniatsova N, Balakrishnan B, Lip GY, Blann AD.

Int J Angiol. 2012 Dec;21(4):195-200. doi: 10.1055/s-0032-1328777.

40.

The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.

Thong KY, McDonald TJ, Hattersley AT, Blann AD, Ramtoola S, Duncan C, Carr S, Adamson K, Nayak AU, Khurana R, Hunter SJ, Ali A, Au S, Ryder RE.

Diabet Med. 2014 Apr;31(4):403-11. doi: 10.1111/dme.12367. Epub 2013 Dec 6.

PMID:
24246138
41.

Soluble P-selectin: the next step.

Blann AD.

Thromb Res. 2014 Jan;133(1):3-4. doi: 10.1016/j.thromres.2013.10.030. Epub 2013 Oct 24. No abstract available.

PMID:
24216322
42.

The effect of statin therapy withdrawal on monocyte subsets.

Jaipersad AS, Shantsila E, Blann A, Lip GY.

Eur J Clin Invest. 2013 Dec;43(12):1307-13. doi: 10.1111/eci.12183. Epub 2013 Oct 18.

PMID:
24134608
43.

The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat.

Sayyed HG, Jaumdally RJ, Idriss NK, El Sers DA, Blann A.

Dig Dis Sci. 2013 Nov;58(11):3156-64. doi: 10.1007/s10620-013-2811-x. Epub 2013 Aug 8.

PMID:
23925818
44.

Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.

Ramcharan SK, Lip GY, Stonelake PS, Blann AD.

Eur J Clin Invest. 2013 Aug;43(8):801-8. doi: 10.1111/eci.12108. Epub 2013 May 18.

PMID:
23683169
45.

Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease.

Blann AD, Kuzniatsova N, Lip GY.

J Hum Hypertens. 2013 Oct;27(10):629-34. doi: 10.1038/jhh.2013.17. Epub 2013 Mar 28.

PMID:
23535991
46.

Atrial fibrillation and thrombosis: the missing molecular links.

Blann AD, Lip GY.

J Am Coll Cardiol. 2013 Feb 26;61(8):861-2. doi: 10.1016/j.jacc.2012.11.047. Epub 2013 Jan 16. No abstract available.

47.

Left ventricular fibrosis in atrial fibrillation.

Shantsila E, Shantsila A, Blann AD, Lip GY.

Am J Cardiol. 2013 Apr 1;111(7):996-1001. doi: 10.1016/j.amjcard.2012.12.005. Epub 2013 Jan 17.

PMID:
23332595
48.

Relationship between vitamin D and red blood cell indices in South Asians and White Europeans.

Marwah S, Walls A, Blann AD.

Br J Biomed Sci. 2012;69(4):182-5. No abstract available.

PMID:
23304797
49.

A procoagulant state and endothelial dysfunction in obese children.

Blann AD.

Br J Haematol. 2013 Mar;160(5):717-8. doi: 10.1111/bjh.12155. Epub 2012 Dec 11. No abstract available.

PMID:
23228096
50.

The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease.

Kuzniatsova N, Shantsila E, Lip GY, Blann AD.

Platelets. 2014;25(2):142-3. doi: 10.3109/09537104.2012.739720. Epub 2012 Dec 5. No abstract available.

PMID:
23216649

Supplemental Content

Support Center